Which treatments for drug-resistant TB are cost effective?
Measuring the cost, cost-effectiveness and efficiency gains of introducing modified short treatment for multidrug or rifampicin-resistance tuberculosis in Belarus, Georgia, Kazakhstan and Moldova.